Lokvančić H. HER2 positive breast cancer and its treatment with trastuzumab, where are we now?. Bioengineering Studies [Internet]. 2022Dec.30 [cited 2026Jun.13];3(2):35-43. Available from: https://www.journals.ardascience.com/index.php/bes/article/view/239